Latent Tuberculosis Infection Rate and TB Incidence among Healthcare Workers in Tertiary Hospitals

Main Article Content

Chamnan Yungthaisong
Phalin Kamolwat
Saijai Smitthikarn
Oranun Lilagud

Abstract

Healthcare workers are the high-risk group for latent tuberculosis (TB) infection. Up to now the studies of the incidence of convertor in the second year, active TB rate and completion rate of latent TB prevention with 3HP regimen are still limited among healthcare workers.


This study was a cross-sectional study from October 2018 to March 2020. An IGRA QuantiFERON-TB Gold Plus (QF-Plus) were used to determine latent TB status. Results showed that the conversion rate in the second year with 35 of 536 persons (6.5%). Factors associated with latent TB infection are the number of beds in the hospital (less than or equal 500 beds and more than 500 beds) with statistically significant (p<0.05), Moreover, an area health correlated to with latent TB infection with statistically significant (p<0.05).


The completion rate of latent TB prevention with 3HP regimen among healthcare workers with 24 of 29 (82.8%). Five of 29 discontinued treatment due to adverse events, rash is the major cause. Among 536 healthcare workers whom IGRA positive, the active TB rate founded 4 persons (0.7%). In summary, Tuberculosis is the major problem in health system in Thailand. Healthcare workers should be annual screened for latent tuberculosis. Early TB preventive treatment for latent TB could be help developing tuberculosis and ending TB in the future.

Article Details

How to Cite
1.
Yungthaisong C, Kamolwat P, Smitthikarn S, Lilagud O. Latent Tuberculosis Infection Rate and TB Incidence among Healthcare Workers in Tertiary Hospitals. IUDCJ [Internet]. 2022 Feb. 27 [cited 2024 Nov. 24];6(2):203-17. Available from: https://he01.tci-thaijo.org/index.php/iudcJ/article/view/253903
Section
Research Articles

References

WHO consolidated guidelines on Tuberculosis. Module 1: prevention – tuberculosis preventive treatment. Geneva: World Health Organization; 2020.

กองวัณโรค. แนวทางการควบคุมวัณโรคประเทศไทย พ.ศ. 2564. พิมพ์ครั้งที่ 1. กรุงเทพฯ: อักษรกราฟฟิคแอนด์ดีไซน์; 2564.

World Health Organization. Global tuberculosis report 2018. Geneva: WHO; 2018: 16-18.

Ditthawat Nonghanphithak,Wipa Reechaipichitkul, Tassamonwan Chaiyasung,Kiaticahi Faksri. Risk Factor for Latent Tuberculosis Infection Among Health-care Workers in Northeatern Thailand. Southeast Asian J Trop Med Public Health. 2016;47(6):1198–208.

บุญเชิด กลัดพ่วง, ชำนาญ ยุงไธสง, ผลิน กมลวัทน์. อัตราความชุกการติดเชื้อวัณโรคระยะแฝงในบุคลากรทางการแพทย์และสาธารณสุขในโรงพยาบาลขนาดใหญ่ จากการตรวจด้วยวิธี Interferon-Gamma Release Assay (IGRA). วารสารโรคเอดส์. 2021;33(1):21–35.

Arguello Perez E, Seo SK, Schneider WJ, Eisenstein C, Brown AE. Management of Latent Tuberculosis Infection Among Healthcare Workers: 10-Year Experience at a Single Center. Clin Infect Dis Off Publ Infect Dis Soc Am. 2017;65(12): 2105–11.

Zwerling A, Benedetti A, Cojocariu M, McIntosh F, Pietrangelo F, Behr MA, et al. Repeat IGRA Testing in Canadian Health Workers: Conversions or Unexplained Variability?. PLoS ONE. 2013;8(1):e54748.

Khawcharoenporn T, Aksornchindarat W, Yodpinij N, Srisungngam S, Rudeeaneksin J, Bunchoo S, et al. T-SPOT®.TB Test for Latent Tuberculosis Infection Diagnosis and Treatment Guidance in Thai Health-Care Professionals. Indian J Occup Environ Med. 2020;24(1):47–9.

Schablon A, Nienhaus A, Ringshausen FC, Preisser AM, Peters C. Occupational Screening for Tuberculosis and the Use of a Borderline Zone for Interpretation of the IGRA in German Healthcare Workers. Diel R, editor. PLoS ONE. 2014;9(12):e115322.

Lee K, Han MK, Choi HR, Choi C-M, Oh Y-M, Lee SD, et al. Annual Incidence of Latent Tuberculosis Infection among Newly Employed Nurses at a Tertiary Care University Hospital. Infect Control Hosp Epidemiol. 2009;30(12):1218–22.

Lee S, Lee W, Kang S-K. Tuberculosis infection status and risk factors among health workers: an updated systematic review. Ann Occup Environ Med. 2021;33:e17.

Zhang X, Jia H, Liu F, Pan L, Xing A, Gu S, et al. Prevalence and Risk Factors for Latent Tuberculosis Infection among Health Care Workers in China: A Cross-Sectional Study. PloS One. 2013;8(6):e66412.

Shahieda A, Rodney E, Roslynn B, Richard N. van Zyl-Smit, Qonita Said-Hartley, Rodney Da, et al. Incidence of occupational latent tuberculosis infection in South African healthcare workers. Eur Respi J. 2015; 45: 1364-73.

Njie GJ, Morris SB, Woodruff RY, Moro RN, Vernon AA, Borisov AS. Isoniazid-Rifapentine for Latent Tuberculosis Infection: A Systematic Review and Meta-analysis. Am J Prev Med. 2018;55(2):244–52.

Sun H-Y, Huang Y-W, Huang W-C, Chang L-Y, Chan P-C, Chuang Y-C, et al. Twelve-dose weekly rifapentine plus isoniazid for latent tuberculosis infection: A multicentre randomised controlled trial in Taiwan. Tuberc Edinb Scotl. 2018;111:121–6.

Pease C, Hutton B, Yazdi, F, Wolfe D, Hamel C, Barbeau P, Skidmore B, Alvarez G.G. A systematic review of adverse events of rifapentine and isoniazid compared to other treatments for latent tuberculosis infection. Pharmacoepidemiol Drug Saf. 2018; 27:557 - 56.

Shiferaw MB, Sinishaw MA, Amare D, Alem G, Asefa D, Klinkenberg E. Prevalence of active tuberculosis disease among healthcare workers and support staff in healthcare settings of the Amhara region, Ethiopia. PLOS ONE. 2021;16(6):e0253177.

Kehinde AO, Baba A, Bakare RA, Ige OM, Gbadeyanka CF, Adebiyi OE. Pulmonary tuberculosis among health care workers at two designated DOTS Centers in urban city of Ibadan, Nigeria. Indian J Med Res. 2011;133:613–7.